EFFICACY OF KANTAKARI AVALEHA AND KANTAKARI GRANULES IN TAMAKA SHWASA.
Phase 2
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2019/04/018465
- Lead Sponsor
- ipgt and ra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients presenting with classical signs and symptoms of Tamaka Shwasa
Exclusion Criteria
Known patients of diabetes and uncontrolled systemic arterial hypertension.Dyspnoea resulting from cardiac origin, severe anemia with Hb%6.Age above 60 years and below 18 years,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IT IS EXPECTED THAT TRIAL DRUG WILL EXTRA A SIGNIFICANT ON SIGNS AND SYMPTOMS OF TAMAKA SHWASATimepoint: 14 months
- Secondary Outcome Measures
Name Time Method IMPROVMENT IN GENERAL HEALTH CONDITION OF PATIENTSTimepoint: AFTER 1 MONTH OF TREATMENT